Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk
- 22 October 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 59 (8) , 1161-1169
- https://doi.org/10.1212/01.wnl.0000028688.75881.12
Abstract
Background: Oxidative damage has been implicated in the pathogenesis of PD. Limited and mostly retrospective epidemiologic data suggest a reduction or no change in risk of PD associated with high vitamin E intake. Objective: To examine prospectively the associations between intakes of vitamins E and C, carotenoids, vitamin supplements, and risk of PD. Methods: The authors documented the occurrence of PD within two large cohorts of men and women who completed detailed and validated semiquantitative food frequency questionnaires. A total of 371 incident PD cases were ascertained in the Nurses’ Health Study, which comprised 76,890 women who were followed for 14 years, and the Health Professionals Follow-Up Study, which comprised 47,331 men who were followed for 12 years. Results: Neither intake of total vitamins E or C or use of vitamin E or vitamin C supplements or multivitamins was significantly associated with risk of PD. The risk of PD, however, was significantly reduced among men and women with high intake of dietary vitamin E (from foods only). The pooled multivariate relative risk (RR) comparing individuals in the highest quintile with those in the lowest quintile was 0.68 (95% CI, 0.49 to 0.93). Consumption of nuts was also significantly associated with a reduced risk of PD (for ≥5/week vs Conclusions: Use of vitamin supplements and high intake of carotenoids do not appear to reduce the risk of PD. The reduction in risk of PD associated with high dietary vitamin E intake suggests that other constituents of foods rich in vitamin E may be protective. Alternatively, moderate amounts of vitamin E may reduce risk of PD, but this benefit may be lost with higher intakes.Keywords
This publication has 50 references indexed in Scilit:
- Parkinson's disease: A chronic, low-grade antioxidant deficiency?Medical Hypotheses, 1994
- Nigrostriatal function in vitamin E deficiency: Clinical, experimental, and positron emission tomographic studiesAnnals of Neurology, 1994
- A Study of the Nutritional Status of Elderly Patients with Parkinson′s DiseaseAge and Ageing, 1994
- Serum levels of β-carotene and other carotenoids in Parkinson's diseaseNeuroscience Letters, 1993
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Comparison of baseline and repeated measure covariate techniques in the Framingham heart studyStatistics in Medicine, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)Neuroscience Letters, 1986
- Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acidNeuropharmacology, 1985
- Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseNeuroscience Letters, 1985